Skip to main content
. 2022 Jun 20;12:10311. doi: 10.1038/s41598-022-13947-y

Table 1.

Patients' information.

Pediatric Age/G Refraction Heterotropia/heterophoria angle Fixation BCVA (logMAR) Interocular BCVA (logMAR) Log stereo Past therapy
Right eye Left eye Right eye Left eye
AA1 7/F + 1.50 − 0.50 180° + 5.00 − 1.50 180° D−, N7∆ EP − 0.02 0.62 0.64 2.30 Occl
S1 9/M + 5.75 − 0.75 150° + 6.00 D8∆, N18∆ EP 0.12 0.20 0.08 2.60 Occl
A1 11/F + 7.00 − 0.75 150° + 1.50 − 0.50 40° 0.30 − 0.08 0.38 2.30
SA1 8/F + 5.00 − 0.25 3° + 6.00 − 0.25 5° D12∆, N− XT 0.00 0.36 0.36 4.00 Occl
AA2 10/F + 0.75 − 0.25 11° + 5.50 − 3.50 179° D2∆, N− XP 0.00 0.30 0.30 2.60
AA3 10/M + 5.50 − 1.50 130° + 1.00 0.10 − 0.10 0.20 1.90 Occl
AA4 6/M + 5.00 − 2.25 180° + 3.00 − 1.00 170° D = N2∆ XP 0.24 0.10 0.14 1.78 Occl
A2 11/F + 1.50 + 6.25 − 0.75 30° − 0.10 0.20 0.30 2.15 Occl
S2 9/M + 3.00 − 0.50 170° + 2.75 − 0.25 179° D4∆, N9∆ ET Ecc 0.30 − 0.02 0.32 4.00 Occl
AA5 7/F + 4.25 − 3.25 15° + 1.75 − 0.25 3° 0.22 0.04 0.18 1.90 Occl
A3 6/M + 6.75 − 0.50 110° + 2.00 − 1.00 90° 0.26 0.02 0.24 1.90 Occl
A4 13/F + 6.25 + 3.50 D2∆, N4∆ EP 0.34 − 0.10 0.44 2.30 Occl
A5* 7/F − 1.25 − 7.00 − 0.10 0.50 0.60 2.15 Occl
SA2 12/M + 2.00 − 1.5 20° + 6.75 − 7.00 165° –† 0.00 0.24 0.24 2.60 Occl
S3 10/F + 5.00 + 5.50 D = N2∆ EP − 0.02 0.44 0.46 3.55 Occl
A6 8/F + 3.50 − 3.75 6° + 4.25 − 3.50 13° 0.30 0.10 0.20 1.70 Occl
SA3 6/M Plan − 2.00 15° − 5.50 − 2.00 150° D20∆, N8∆ XP 0.02 0.34 0.32 4.00 Occl
AA6 10/M + 7.75 − 0.75 20° + 8.00 − 1.00 135° 0.00 0.16 0.16 1.78 Occl
A7* 7/F + 1.25 + 4.50 − 0.04 0.14 0.18 1.90 Occl
SA4 10/F + 4.00 − 1.00 20° + 6.50 D9∆, N10∆ ET 0.04 0.24 0.20 2.30 Occl
AA7* 6/M − 1.00 − 1.50 12° + 0.75 − 0.25 15° 0.16 0.02 0.14 1.90 Occl
AA8 7/F + 1.75 − 1.25 165° − 5.00 − 1.25 20° 0.14 0.66 0.52 2.90 Occl
S4 11/F + 1.75 − 1.75 3° + 2.00 − 1.75 5° D− , N7∆ EP 0.20 0.00 0.20 2.30
A8 8/M + 3.75 − 0.25 36° + 6.00 − 0.50 174° − 0.02 0.16 0.18 2.15 Occl
S5 10/M + 2.00 − 2.00 180° + 1.50 − 1.50 180° D4∆, N7∆ EP 0.18 0.06 0.12 2.60 Occl
AA9 5/M + 2.00 − 0.50 10° + 5.00 − 3.50 165° 0.04 0.34 0.30 1.70
SA5 7/M − 3.00 − 1.50 70° + 0.75 − 0.75 90° D− , N10∆ EP 0.48 0.10 0.38 4.00 Occl
mean 8.55
sd 2.12
Adult
SA6 38/F + 0.50 − 0.75 170° (5∆ base-out) − 0.50 − 0.75 35° (5∆ base-out) D = N7∆ ET Ecc 0.86 0.04 0.82 4.00 Occl
S7 44/F + 3.50 + 3.25 D−, N6∆ ET 0.08 0.00 0.08 4.00 Occl
AA10 38/M − 4.25 − 3.00 150° − 2.50 0.32 − 0.18 0.50 1.60
SA7 46/M + 2.00 + 4.50 − 4.00 24° D4∆, N6∆ ET − 0.12 0.50 0.62 4.00 Occl
A9 47/F + 4.50 (add + 0.75) + 3.75 (add + 0.75) 0.46 − 0.24 0.70 2.60
A10 39/F − 0.50 − 0.25 141° + 3.50 − 0.75 43° − 0.16 0.54 0.70 2.30
SA8 40/M − 7.75 − 3.75 175° − 3.00 − 0.50 25° D = N12∆ XP 0.46 − 0.20 0.66 1.60 Occl
S8 29/M − 0.25 − 0.25 111° − 0.75 − 0.50 89° D8∆, N2∆ EP 0.64 − 0.06 0.70 2.30 Occl
AA11 29/M − 0.25 + 5.25 − 2.75 61° − 0.10 0.40 0.50 2.15 Occl
S9 34/M + 1.00 (4∆ base-out) + 1.25 (4∆ base-out) D = N10∆/2∆, ET/HypoT − 0.26 0.94 1.20 4.00 Occl
S10 34/F − 0.75 − 0.50 96° − 0.75 − 1.25 74° − 0.10 0.20 0.30 2.60
A11 27/F + 4.50 − 1.50 180° − 0.50 − 0.75 152° 0.42 − 0.16 0.58 4.00
S11 46/M Plan − 1.25 110° (add + 1.25) + 0.25 − 1.50 75° (add + 1.25) Ecc 0.02 0.50 0.48 2.60 Occl
A12 31/M + 4.50 − 1.00 180° + 3.25 − 0.75 30° 0.64 0.04 0.60 3.55 Occl
AA12 26/M Plan + 5.00 − 1.00 175° − 0.22 0.90 1.12 4.00
AA13 19/F − 0.50 − 1.50 175° − 5.75 − 3.00 20° 0.00 0.20 0.20 1.70 Occl
SA9 28/M + 1.00 − 0.50 93° + 4.00 − 0.75 71° D = N6∆ ET Ecc − 0.16 0.76 0.92 4.00 Occl
A14 43/M − 0.50 − 0.50 160° + 2.50 − 0.08 0.48 0.56 2.30
mean 34.09
sd 8.97

A spherical anisometropia, AA spherical and astigmatic anisometropia, S strabismus, SA mixed amblyopia, G gender, F female, M male, BCVA best-corrected visual acuity, D distance, N near, ET esotropia, XT exotropia, EP esophoria, XP exophoria, Ecc eccentric fixation, Occl occlusion therapy.

*Patients dropped out from the therapy.

Patients undergone strabismus corrective surgery.